⌘K

Login Start Free

Zomedica Pharmaceuticals Corp.|4Mar 30, 4:04 PM ET

Herbst Bruk 4

4 · Zomedica Pharmaceuticals Corp. · Filed Mar 30, 2018

Insider Transaction Report

Form 4

Period: 2018-03-29

Zomedica Pharmaceuticals Corp.ZOM

Chief Commercial Officer

Transactions

Exercise/Conversion
Common Shares, without par value
2018-03-29$2.20/sh+62,996$138,591→ 62,996 total
Exercise/Conversion
Stock Option (right to buy)
2018-03-29−62,996→ 137,004 total
Exercise: $2.20From: 2017-08-14Exp: 2019-08-14→ Common Shares, without par value (62,996 underlying)

Holdings

Common Shares, without par value
(indirect: By daughter)
1,000
Common Shares, without par value
(indirect: By daughter)
1,000
Common Shares, without par value
(indirect: By son)
1,000

Footnotes (1)

[F1]The options vested upon grant. The option is currently fully vested.

Documents

1 file

4
zomedica_form4mar292018.xmlPrimary
OWNERSHIP DOCUMENT